PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptNIH Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
J Immunol. Author manuscript; available in PMC Aug 1, 2012.
Published in final edited form as:
PMCID: PMC3262882
NIHMSID: NIHMS342574
Clonotype and repertoire changes drive the functional improvement of HIV-specific CD8 T cell populations under conditions of limited antigenic stimulation
Loury Janbazian,* David A. Price, Glenda Canderan,§ Abdelali Filali-Mouhim,* Tedi E. Asher, David R. Ambrozak, Phillip Scheinberg, Mohamad Rachid Boulassel, Jean-Pierre Routy, Richard A. Koup, Daniel C. Douek, Rafick-Pierre Sekaly,*§||# and Lydie Trautmann§#
*Laboratory of Immunology, Department of Microbiology and Immunology, Université de Montréal, Montreal, H2X 1P1, Canada
Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
Institute of InfectionandImmunity, Cardiff University School of Medicine, Cardiff, CF14 4XN, Wales, UK
§Vaccine and Gene Therapy Institute - Florida (VGTI-FL), Port Saint Lucie, FL 34987, USA
Division of Hematology, Royal Victoria Hospital, McGill University Health Centre, Montreal, H3A 1A1, Canada
||Faculty of Medicine, Department of Microbiology and Immunology, McGill University, Montreal, H3A 2B4, Canada
#Department of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, FL 33101, USA
Correspondence: Lydie Trautmann, VGTI-FL, 11350 SW Village Parkway, Port Saint Lucie, FL 34987, USA. Tel:+1 772 345 4780. Fax:+1 772 345 3675. ltrautmann/at/vgtifl.org
Persistent exposure to cognate antigen leads to the functional impairment and exhaustion of HIV-specific CD8 T cells. Antigen withdrawal, due either to antiretroviral treatment or the emergence of epitope escape mutations, causes HIV-specific CD8 T cell responses to wane over time. However, this process does not continue to extinction, and residual CD8 T cells likely play an important role in the control of HIV replication. Here, we conducted a longitudinal analysis of clonality, phenotype and function to define the characteristics of HIV-specific CD8 T cell populations that persist under conditions of limited antigenic stimulation. Antigen decay was associated with dynamic changes in the TCR repertoire, increased expression of CD45RA and CD127, decreased expression of PD-1 and the emergence of poly-functional HIV-specific CD8 T cells. High definition analysis of individual clonotypes revealed that the antigen loss-induced gain of function within HIV-specific CD8 T cell populations could be attributed to two non-exclusive mechanisms: (i) functional improvement of persisting clonotypes; and, (ii) recruitment of particular clonotypes endowed with superior functional capabilities.
Several observations suggest that antigen-specific CD8 T cells are important for the control of HIV-1 infection (1-4); it has also been demonstrated that HIV-specific CD8 T cell responses in long-term non-progressors (LTNPs) and in HLA-B*27+slow progressorsexhibit a wide array of effector functions (5, 6). However, chronic antigen persistence at high levels leads to dysfunction and exhaustion, and HIV-specific CD8 T cells are therefore frequently characterized by an inability to produce cytokines, compromised proliferative capacity and impaired cytotoxic activity(7-13). Despite the widespread usage of highly active antiretroviral therapy (HAART), relatively little is known about its impact on HIV-specific CD8 T cells. The frequency of such cells declines rapidly upon the initiation of HAART (14-16). Nevertheless, persisting HIV-specific CD8 T cells could still play an important role in controlling residual viral replication. Similarly, despite the fundamental significance of perpetual viral evolution in relation to disease pathogenesis, relatively little is known about the impact of immune escape on HIV-specific CD8 T cells. Of note, de novo variant-specific CD8 T cell responses can emerge, suggesting thatsome of these escape mutations can still be processed and presented to T cells (17). Furthermore, it is known that responses specific for wildtype epitopes wane over time due to diminished antigenic drive, yet this process does not lead to the extinction of CD8 T cells that recognize wild type epitopes. Thus, CD8 T cells with wildtype epitope specificity persist in some form and appear to play an important role in the maintenance of escape mutations within the viral quasispecies. Strong evidence for this assertion comes from HIV and SIV transmission studies, in which selected escape mutations rapidly revert to optimize viral fitness in the absence of the presenting major histocompatibility complex class I (MHCI) molecule and remain relatively stable in the presence of the appropriate restriction element due to the induction of wild type-specific CD8 T cell populations by viral revertants(18-21).
It was recently documented that both HAARTand viral sequence diversification lead to the emergence of poly-functional HIV-specific CD8T cells (22, 23).Rehr et al. demonstrated that, after 24 weeks of HAART, HIV-specific CD8 T cells gradually recovered their cytokine secretion capacity, displayed increased expression of CD28 and CD127, and down-regulated PD-1(22). Furthermore, Streeck et al. showed that antigen decay over time decreased the exhausted phenotype of HIV-specific CD8 T cells, while mono-functionality decreased slightly for responses directed against escaped epitopes (23). In another study, it was shown that antigen decay resulting from the emergence of escape mutations or the institution of HAART was associated with significantly decreased co-expression of CD38 and PD-1 on HIV-specific CD8 T cells, whereas a rise in viral load resulted in increased CD38/PD-1 co-expression(24). However, the characteristics of the clonal T cell receptor (TCR) repertoire under conditions of limited antigenic stimulation remain unknown.
AlthoughTCR repertoire studies have been performed in the context of several acute and persistent viral infections including HIV-1 (25-29), longitudinal studies that aim to characterize the evolution of the HIV-specific CD8 T cell repertoire and further couple HIV-specific CD8 T cell clonotypes to functional profiles have been limited(30). Here, we hypothesized that antigen decay would enhance the functional quality of HIV-specific CD8 T cell responses by influencing the antigen-specific CD8 T cell repertoire. Accordingly, to better define the qualitative features of HIV-specific CD8 T cells during antigen withdrawal, we undertook a comprehensive analysis of HIV-specific CD8 T cell responses in the face of antigen decay due to the initiation ofHAART or the emergence of viral epitope mutations in a cohort of 8 HIV-infected individuals. In each case, we conducted a longitudinal examination of the clonal composition, phenotypic status and functional profile of CD8 T cell populations specific either for autologous stable epitopes at time points prior to, during and after HAART or for autologous wild type epitopes and, where present, the corresponding variant epitopes before and after viral escape. For comparative purposes, CMV-specific CD8 T cell responses were studied in parallel. The data provide clear evidence for dynamic changes in the TCR repertoire associated with anantigen loss-mediated functional reconstitution within the HIV-specific CD8 T cell compartment, which can be attributed to two distinct mechanisms: (i) functional improvement of persistent clonotypes; and, (ii) recruitment of particular clonotypes endowed with superior functional capabilities.
Study participants
Eight HIV-infected subjects were enrolled from Hospital Notre Dame, Montreal, Quebec, Canada. All were male, aged between 22 and 49 years (mean, 38 years).The estimated date of infection in each case was based on clinical history, p24 ELISA and Western Blot HIV Test analysis. Longitudinal cryopreserved peripheral blood mononuclear cell (PBMC) samples were available from each subject and written informed consent for sample use was obtained in all cases. Subjects 1, 2, 3, 4 and 8 started HAART during the course of the study; subjects 5, 6 and 7 were treatment-naïveduring the course of the study.Subjects 1, 2 and 3 started HAART during early phase HIV-1 infection(1 month after infection); subjects 4 and 8 started HAART 6 months after the estimated date of infection. All 5 subjects stopped HAART voluntarily. Initial immunological characterization comprised HLA genotyping and screening for HIV epitope-specific CD8 T cell responses usingfluorescent peptide-MHCI (pMHCI) tetrameric complexes based on autologous viral sequences; CMV-specific CD8 T cells were only detected in subjects 1,2, 4 and 8.
Autologous viral sequencing
For bulk analysis of autologous viral populations, amplification and sequencing of the near complete HIV genomes was performed as described previously(31). For clonal sequencing, viral RNA was extracted using the QIAamp viral RNA minikit (Qiagen) and reverse transcribed using the SuperScript One-Step RT-PCR kit (Invitrogen). Amplification was performed using sets of outer primers specific for each region of interest. Products were then further amplified in a nested PCR using specific sets of inner primers. Amplicons were ligated into pGEM-T Easy vector (Promega) and cloning was performed by transformation of competent DH5-α E. coli. For each amplicon, 24 white colonies were picked, screened using standard M13 primers and then sequenced. All sequences were analyzed using Codon Code Aligner Version 3.0 (Codon Code Corporation).
Tetrameric pMHCI complexes
Soluble biotinylated pMHCI monomers were manufactured by the CANVAC tetramer core facility (Montreal, Canada) as described previously(32) and tetramerized with fluorochrome-conjugated streptavidin at a 4:1 molar ratio. The following pMHCI tetramers were produced: HLA-A*0201-FLGKIWPSHK (HIV Gag p2p7p1p6 FL10, residues 70-79) and HLA-A*0201-NLVPMVATV (CMV pp65 NV9, residues 495-503) forsubject 1, HLA-A*0301-RLRPGGKKR (HIV Gag p17 RR9, residues 20-28) and HLA-B*0702-TPRVTGGGAM (CMV pp65 TM10, residues 417-426) for subject 2, HLA-B*0801-FLKEKGGL (HIV Nef FL8, residues 90-97) forsubject 3, HLA-B*0702-TPGPGVRYPL (HIV Nef TL10, residues 128-137) and HLA-B*0702-TPRVTGGGAM (CMV pp65 TM10, residues 417-426) for subject 4, HLA-B*0702-FPQGEAREL (HIV Pol FL9, residues 8-16), a novel epitope predicted on the basis of binding algorithms and autologous viral sequence data, for subject 5, HLA-A*0301-RLRPGGKKK (HIV Gag p17 RK9, residues 20-28) for subjects 6 and 7, and HLA-B*0801-GEIYKRWII (HIV Gag p24 GI9, residues 127-135) and HLA-B*0702-TPRVTGGGAM (CMV p65 TM10, residues 417-426) for subject 8. Tetrameric complexes with the variant epitope HLA-A*0301-RLRPGGRKR were also produced for experiments conducted with samples from subject 7.
Phenotypic analysis of antigen-specific CD8 T cells
Thawed PBMC were stained with PE- or APC-conjugated pMHCI tetramers for 15 min at 37°C, then washed and surface stained with panels constructed from combinations ofthe following monoclonal antibodies (mAbs): (i) αCD3-Pacific Blue, αCD8-PerCPCy5.5, αCCR7-FITC,αCCR7-PECy7, αCD27-Alexa700, αCD27-Qdot605,αCD28-FITC, αCD45RA-APCCy7, αCD127-Pacific Blue, αCD127-PECy5, αPD-1-APC, αPD-1-PECy7and αIFN-γ-APC(BD Biosciences); and, (ii)αCD8-ECD and αVβ6-2-PE (Beckman Coulter). Live/dead fixable Aqua (Invitrogen) was used to exclude dead cells from the analysis.Data were collected using an LSRII flow cytometer (BD Biosciences) and analyzed with FlowJo software (version 8.7.3; TreeStar Inc.); compensation was performed electronically andthe Boolean platform was used to create arrays of different marker combinations. Subsequent analysis was performed using SPICE software (version 5.1; http://exon.niaid.nih.gov/spice/)(33).
Functional analysis of antigen-specific CD8 T cells
Cryopreserved PBMC were thawed and rested for 1 hr in R10 (RPMI 1640 medium supplemented with 10% fetal calf serum, antibiotics and L-glutamine) prior to stimulation with cognate peptide. Stimulated samples were pre-stained with the corresponding PE-conjugated pMHCI tetramers for 15 min at 37°C. After addition of the co-stimulatory mAbs αCD28 and αCD49d (1 μg/ml each; BD Biosciences), monensin (0.7 μg/ml; BD Biosciences), brefeldin A (10 μg/ml; Sigma-Aldrich) and αCD107a-Alexa680, cells were stimulated with the relevant autologous peptides at a concentration of 5 μg/ml for 6 hr at 37°C. Co-stimulation alone and staphylococcal enterotoxin B (1 μg/ml; Sigma-Aldrich) were used as negative and positive controls, respectively; in all cases, cells in the negative control tubes were stained with pMHCI tetramers at the end of the stimulation period. After a single wash, the cells were stained with αCD3-Pacific Blue andαCD8-ECD,then washed again prior to fixation/permeabilization (2% paraformaldehyde / 0.05% saponin) and intracellular staining with αIL-2-FITC, αTNF-Alexa700 and αIFN-γ-APC (BD Biosciences). Live/dead fixable Aqua (Invitrogen) was used to exclude dead cells from the analysis. Antigen sensitivity was assessed using a similar protocol for the measurement of intracellular IFN-γ after stimulation with a ten-fold dilutional series of cognate peptide from 10 μg/ml to 0.0001 μg/ml; experiments were performed in triplicate and the EC50 was defined as the peptide concentration that yielded 50% of the maximum IFN-γ response. For all experiments, data were acquired immediately using an LSRII flow cytometer (BD Biosciences) after a final wash step and fixation with 2% paraformaldehyde. All live lymphocyte events were collected and files were analyzed with FlowJo software (version 8.7.3; Tree Star Inc.) after electronic compensation. Functional capacity was determined after Boolean gating and subsequent analyses were performed using SPICE software (version 5. 1; http://exon.niaid.nih.gov/spice/)(33). Values used for the analysis of proportionate response representation were background subtracted.
TCR clonotype analysis
For RNA-based clonotype analysis, HIV-specific CD8 T cells were stained with cognate pMHCI tetramer and sorted viably to >98% purity by flow cytometry directly into 1.5 ml Sarstedt tubes containing 100 μl RNAlater (Applied BioSystems). mRNA was extracted using the Oligotex mRNA mini kit (Qiagen) and subjected to a template-switch anchored RT-PCR using a 3′ TRB constant region primer as described previously(34). Amplicons were ligated into pGEM-T Easy vector (Promega) and cloned by transformation of competent DH5-α E. coli. At least 50 white colonies were amplified by PCR for each sorted population using standard M13 primers and then sequenced. For DNA-based clonotype analysis, distinct functional CD8 T cell subsets were sorted to >98% purity by flow cytometry after intracellular cytokine staining. DNA was extracted by lysis of sorted T cells in 100 μg/ml proteinase K (Boehringer) for 1 hr at 56°C and then 10 min at 95°C. A hemi-nested multiplex touchdown PCR was then performed using previously described TRBV/TRBJ primer combinations and PCR conditions(35). Amplicons were then subcloned using the pGEM-T vector system and sequenced.All sequences were analyzed using Sequencher (Gene Codes Corp.); non-functional sequences were discarded from the analysis. The ImMunoGeneTics (IMGT) nomenclature is used throughout the manuscript.
Statistical analyses
Statistical analysis was performed using the two-tailed Student’s paired T-test for the data shown in Figures 2 and and3;3; the Wilcoxon rank sum test was used for the analyses shown in Figure 4. P < 0.05 was considered significant. The similarity of the TCR repertoire between time pointsand estimation of the reference similarity were assessed using the Morisita-Horn coefficient, calculated according to the method developed by Venturi et al.(36).The size of all samples was reduced to the size of the smallest sample, and the Morisita-Horn similarity indices were computed as if a standard number of 26 TCR sequences had been obtained in all samples. The randomization step consisted of randomly drawing a sample size of 26 in the antigen high (Ag), antigen low (NoAg) and antigen rebound (ReAg) states, and calculating the similarity measures for each sample pair of Ag/NoAg and Ag/ReAg. The distribution median resulting from 10,000 random samplings of the two reduced sample pairs was used to represent the Morisita-Horn similarity indices between the Ag/NoAg and between the Ag/ReAg subsets.We also determined whether the similarities for the observed TCR sample pairs were lower than expected by chance, if the sample pairs had been randomly assigned from the same TCR population. The reference similarity was generated under the null hypothesis that the Ag and NoAg sets were randomly assigned from the same TCR population. The TCR sequences of Ag and NoAg states were first pooled, then two sets of 26 TCR sequences were randomly drawn from the pooled populations to calculate the similarity measures. The median of this distribution provided a reference similarity for the two TCR repertoire sets, namely HIV Ref and CMV Ref.
Figure 2
Figure 2
Phenotypic changes in HIV-specific CD8 T cell populations under conditions of reduced antigen load
Figure 3
Figure 3
Functional changes in HIV-specific CD8 T cell populations under conditions of reduced antigen load
Figure 4
Figure 4
Evolution of the TCR repertoire in the context of antigen decay
Virological and immunological features of the study population
The clonal structures, functional profiles and phenotypic properties of HIV-specific CD8 T cell populations were studied longitudinally in 8HIV-infected individuals under conditions of bothhigh and low antigen load, as inferred from measurements of plasma viremia and autologous viral epitope sequencing, with low levels of antigenemia reflecting HAART-mediated suppression of HIV replication and/or immune-driven mutational escape. Where feasible, CMV-specific CD8 T cell responses were studied in parallel. Figure 1A depicts the time points studied in each subject and the autologous viral epitope sequences for the specificities studied at each time point. Periods of reduced antigen load, due to effective HAART and/or viral escape, are indicated by diagonal hatching. Supplementary Figure 1 displays the viral load trajectories for each subject together with concomitant CD4 and CD8T cell counts, and all viral epitope sequences. For subjects 1-4, there was no evidence of mutation within any of the targeted epitopes throughout the study period (Figure 1A & Supplementary Figure 1B). For subjects 5-8, autologous plasma viral sequencing revealeddirectional changes in antigenic sequences over time (Figure 1A & Supplementary Figure 1B), consistent with epitope escape through mutation at MHCI anchor positions and/or putative TCR contact residues (subjects 5, 7 and 8). In subject 5, we observed E8K and L9F mutations in the Pol FL9 epitope. In subject 6, 100% of analyzed sequences acquired a K9Q mutation in the Gag p17 RK9 epitope over the course of the study. In subject 7, a dual K7R and K9R mutation was observedin the Gag p17 RK9 epitope. However, at the final time point of the study (26 months), the majority of viral sequences contained the K9R mutation either alone or in combination with additional mutations; this indicates replacement of the intermediate viral quasispecies with an optimal immune escape virus. In subject 8, I3V and R6K mutations emerged in the Gag p24 GI9 epitope at 17 months. Of note, subject 8 initiated HAART after the first time point of study and exhibited an undetectable plasma viral load at 7 months. Representative dualpMHCI tetramer stainings are shown in Figure 1B. Consistent with antigen load decay, we observed a progressive decline of HIV-specific CD8 T cell frequencies in all 8 subjectsafter initiation of HAART and/or the emergence of targeted epitope escape mutations (Figure 1C). In contrast, the frequencies of CMV-specific CD8 T cells remained largely constant(37). Of note, the frequencies of HIV-specific CD8 T cells all increased with antigen rebound after cessation of HAART in subjects 1-4.
Figure 1
Figure 1
Virological and immunological characteristics of the study cohort
Antigen load decay leads toincreased expression of CD45RA and CD127and decreased expression of PD-1 on HIV-specific CD8 T cells
Flow cytometric analysis using a panel of cell surface markers allowed us to assess the maturation status (monitored by the expression of CCR7, CD27 and CD45RA; Figure 2A&C), exhaustion profile and survival capacity (quantified by theexpression of CD28, CD127 and PD-1; Figure 2B&D) of HIV-specific CD8 T cell populations longitudinally in 7subjects. The full dataset is shown in Supplementary Figure 2. In agreement with previous results, HIV-specific CD8 T cells generally expressed either a CCR7CD27+CD45RA or a CCR7 CD27CD45RA phenotype (38). Frequencies of CCR7CD27+CD45RA cells (medium blue) declined as levels of antigen decreased, with the exception of subject 4, while the proportion of CD45RA+ cells (dark blue) increased for all subjects.This increase in CD45RA expressioncomprisedboth CCR7CD45RA+ cells,reflecting differentiation within the memory compartment, andCCR7+CD45RA+ cells, a phenotype that typifies naïve or stem-cell memory(Tscm) cells(39). Figure 2E represents the significant increase of HIV-specific CD8 T cells expressing CD45RA between the first time point, where antigen load was high, and the second time point obtained after antigen decline for all subjects studied (P=0.005). Similarly, and concomitantly with the decay in antigen level, the frequency of CD28+/−CD127PD-1+ CD8 T cells (medium pink) decreased in all subjects, while frequencies of CD28+/−CD127+PD-1+/−CD8 T cells (purple)increased in all subjects except subject 4. The significant increase in CD127 expression and decrease in PD-1 expressionon HIV-specific CD8 T cells between the first time point studied and the second time point after antigen decline is shown in Figure 2F&G (P=0.006 and P=0.011, respectively). In contrast, CMV-specific CD8 T cells displayed a more terminally differentiated phenotype (CCR7CD27CD45RA−/+); these cells were mostly CD28CD127+/−PD-1 and did not show consistent phenotypic changes during the study course (Supplementary Figure 2B&D). Collectively, these results indicate that HIV-specific CD8 T cells lose expression of the exhaustion marker PD-1 and up-regulate CD127 expression levels under conditions of reduced antigen load, which could allow them to persist within the memory compartment (40); moreover, the increase in CD45RA expression indicates that decreased levels of antigen lead to enhanced differentiation within the specific CD8 T cell compartment as a whole.
Reduced antigenemia improves the functionality of residual HIV-specific CD8 T cells
To determine if changes in antigen levels, mediated either by intervention with HAART or immune-driven viral escape, led to significant changes in the functional profile of HIV-specific CD8 T cells, we undertook a comprehensive flow cytometric analysis of cytokine production (IFN-γ, TNF and IL-2) and degranulation (CD107a) in all 8subjects (Figure 3 and Supplementary Figure 3). Weused Boolean analysis to create an array of different combinations of T cell functions that allowed the enumeration of cells with various degrees of functionality. Figure 3A shows representative flow cytometric data for CD107a mobilization and IFN-γ, TNF and IL-2 production by HIV-specific or CMV-specific CD8 T cells in the presence of cognate peptide stimulation. We observed dynamic changes in the functionality of HIV-specific CD8 T cells in all subjects studied as levels of cognate antigen decayed (Figure 3B&C); the full dataset is shown in Supplementary Figure 3A. For all 8 subjects, HIV-specific CD8 T cell responses at the early time points of high viremia were predominantly mono- or bi-functional, mainly comprising IFN-γ+ and/or CD107a+ cells. Interestingly, the functional profile of HIV-specific CD8 T cells for each epitope was characterized by the acquisition of several functions following antigen load decay as shown by a significant increase in the frequencies of cells exhibiting 3 functions (CD107a+IFN-γ+TNF+; orange; P=0.01)and a decay in mono- or bi-functional cells (yellow and green; Figure 3B-D). Of note, after antigen rebound due to cessation of HAART, the frequency of HIV-specific CD8 T cells exhibiting 3 or 4 functions (orange, red) decreased in subjects 1 to 4. No significant changes in functionality were apparent for the corresponding CMV-specific CD8T cell populations (Supplementary Figure 3B). Indeed,CMV-specific CD8 T cells were consistently poly-functional, exhibiting up to 4 (CD107a+IFN-γ+TNF+IL-2+), 3 (CD107a+IFN-γ+TNF+) or 2 (IFN-γ+TNF+ and CD107a+IFN-γ+) functions.Thus, HIV-specificCD8 T cells display enhanced poly-functional profiles coincident with the decay of antigen, whether due to effective HAART or the emergence of escape mutations, consistent with previous reports (22, 23).
Changes in the HIV-specific CD8 T cell repertoire after antigen decay
To determine if the changes in phenotype and functionality that followed the decay of antigen levels could be attributed to alterations in the TCR repertoire of HIV-specific CD8 T cells, we performed a comprehensive clonotypic analysis of HIV-specific and CMV-specific CD8 T cell populations using a template-switch anchored RT-PCR to amplify all expressed TRB gene products without bias as described previously(34, 41). All TCR sequences from this longitudinal analysis are shown in Supplementary Table 1. Figure 4A summarizes the dynamic evolution of the major clonotypes, color-coded to match the sequences shown in Supplementary Table 1. Dynamic longitudinal changes in clonotypic composition were observed within HIV-specific CD8 T cell populations, concomitant with changes in antigen load. Several clonotypes persisted throughout the duration of the study,while others could no longer be detected. Furthermore, we observed the emergence of new clonotypes during periods of HAART administration and after the emergence of escape mutations. Persistent clonotypes showed quantitative changes as a consequence ofantigen load decay. In subject 1, for example, the TRBV6-2/CASSYVGGDGYT/TRBJ1-2 clonotype, which was the second most frequent clonotype in the pre-HAART repertoire (27.7%), increased in frequency during therapy and became the prevalent clonotype after cessation of HAART and viral load rebound (87.6%). In subjects 6 and 8, an even more dramatic shift was observed, with a monoclonal repertoire emerging after immune escape; the detected TRBV13/CASSPGLDGEQY/TRBJ2-7 clonotype for subject 6 and the TRBV9/CASSTKAGGLADTQY/TRBJ2-3 clonotype for subject 8 were not present at the pre-escape time point. In subject 5, we observed a major bias in the TCR repertoire specific for the HLA-B*0702-FPQGEAREL epitope, with preferential usage of TRBV18 and TRBJ2-5 combined with the presence of a discernable RGR motif in the CDR3 loop. More over, clonotype TRBV18/CASSPRGREETQY/TRBJ2-5, which was a subdominant clonotype at 7 and 21 months (13.4% and 16.1% respectively), became dominant at 31 and 43 months (100% and 98%, respectively). Of note, the dominant clonotype at 7 and 21 months, TRBV18/CASSPRGRDETQY/TRBJ2-5, could no longer be detected within the tetramer+ pool at 31 and 43 months. Hence, in the context of the E8K and L9F mutations, we observed the selection of a single clonotype from a heavily biased repertoire that persisted over time. In subject 7, the TCR repertoires specific for the wild type (RLRPGGKKK) and variant (RLRPGGRKR) epitopes were analyzed. Responses to both epitopes were detected and decayed over time (Figure 1C). The TCR repertoire specific for the wild type epitope remained stable. The dominant clonotype specific for the variant epitope that emerged under low levels of antigen at 16 months (TRBV10/CASSDTLNTEAF/TRBJ1-1) was not detected in either repertoire prior to immune escape; however, it was detected as a subdominant clonotype in the wild type epitope-specific repertoire post-escape. Other cross-reactive clonotypes were also detected at 2 and 16 months (TRBV28/CASRDSSYEQY/TRBJ2-7 and TRBV24-1/CATSDDGTPNNEQF/TRBJ2-1), and both repertoires contained mutually exclusive clonotypes. Thus, immune escape through mutation can impact the clonotypic repertoire of wild type epitope-specific CD8 T cell populations.
Figure 4B displays the similarity indices for TCR sequences between time points with high and low antigen load for HIV-specific and CMV-specific CD8 T cell populations calculated using the Morisita-Horn coefficient for all subjects (36). All values were generated in comparison to the first time point, when antigen levels were high. HIV-specific CD8 T cell repertoires exhibited drastic changes as the Morisita-Horn coefficients were lower than 1, except for subject 3. For all 4 subjects in whom CMV-specific responses were detected, the Morisita-Horn coefficient was equal or close to 1, indicating a conserved repertoire throughout the study period.The TCR repertoire similarity between the high and low antigen load time points was significantly lower than the reference similarities for HIV-specific CD8 T cells (P=0.001), suggestingthat the HIV-specific CD8 T cell repertoire population was highly dynamic upon decrease of antigen load. For subjects 1 to 4, the Morisita-Horn coefficients ranged from 1 to 0.56 for the HAART-induced low antigen load time points studied (Figure 4C). After antigen rebound, these coefficients were significantly lower compared to those observed between high and low antigen load states (P=0.04), indicating a further turnover of the HIV-specific TCR repertoire upon antigen rebound (Figure 4C). Collectively, these results indicate that the HIV-specific TCR repertoire is highly dynamic and that fluctuations in antigen levels (decay and rebound) lead to changes in clonal dominance by selection of particular persistent clonotypes and the emergence of new HIV-specific CD8 T cell clonotypes.
Functionally superior HIV-specific CD8 T cells persist under conditions of limited antigenic stimulation
In 3 subjects, we were able todissect the functional characteristics of individual persistent clonotypesbased on the availability of specific TCRVβmAbs. The TRBV25-1/CASSVLRAAF/TRBJ1-1 clonotype dominated the HLA-B*0801-restricted FL8-specific CD8 T cell population in subject 3 at the 1 month (high antigen load, 97.7%) and 8 month(low antigen load on HAART, 100%)time points. This clonotype displayed a change in phenotype between the pre-HAART and HAART time points, predominantly due to increased expression of CD45RA (dark blue) and CD127 (purple), and a decrease in PD-1 expression (medium pink)(Figure 5A). Gain of function between these two time points was also apparent, as evidenced by a substantial increasein the frequencies of CD107a+IFN-γ+ TNF+ (3+) cells, from 1.6% to 33.6% of the responding population (Figure 5A). However, this gain in functionality under conditions of limited antigenic stimulation was not sufficient to maintain the TRBV25-1/CASSVLRAAF/TRBJ1-1 clonotypeafter antigen rebound, as it was replaced by a new clonotype post-HAART (Figure 5A and Supplementary Table 1). Thus, a decrease in antigen load can lead to phenotypic changes and increased functionality at the clonal level.
Figure 5
Figure 5
Gain of function and persistence of individual HIV-specific CD8 T cell clonotypes under conditions of limited antigenic stimulation
The clonotypic and functional analysis from subject 1supported this observation and suggested another mechanism for the gain of function after antigen decay (Figure 5B). ClonotypeTRBV6-2/CASSYVGGDGYT/TRBJ1-2 persisted throughout the study period, although its relative frequency progressively increased such that it became the dominant clonotype during and after HAART (58.7% at 17 months and 87.6% at 20 months, respectively). Functionality was assessed both within the total HLA-A*0201-restricted FK10-specificCD8 T cell population encompassing several clonotypes and within the TCRVβ6-2+subset, identified by mAb staining; this analysis was performed at time points that preceded and followed antigen decay (1 month and 17 months, respectively), when the TRBV6-2/CASSYVGGDGYT/TRBJ1-2 clonotype (in blue) was subdominant and dominant respectively (Figure 5B). At 1 month, tetramer+CD8 T cells were predominantly IFN-γ+. Interestingly, the functional profile of TCRVβ6-2+CD8 T cells was similar to that of the total tetramer+CD8 T cell population at this time point. After antigen decay on HAART at 17 months, the functional profile of the tetramer+CD8 T cell population remained predominantly mono-functional. In contrast, TCRVβ6-2+CD8 T cells acquired novel functions, demonstrated by an increase in the proportion of CD107a+IFN-γ+TNF+ (3+) cells. At 17 months, no differences in phenotype were observed between the TCRVβ6-2+cells and the total FK10-specific CD8 T cell population (Figure 5B). Thus, fluctuations in antigen load can lead to clonotype-specific functional changes. Furthermore, clonotypes that display enhanced functionality can become numerically dominant under conditions of limited antigenic stimulation.
To extend these observations, experiments were performed to determine if clonotypes with superior functional profiles were endowed with a greater capacity to persist. The clonotypic and functional data from subject 5 allowed us to address this question (Figure 5C). Functional improvements in the HLA-B*0702-restricted FL9-specific CD8 T cell population after antigen decay at 31 and 43 months were described above (Figure 3). The TCR repertoire of the HLA-B*0702-restricted FL9-specific CD8 T cell population was comprised of a single clonotype,TRBV18/CASSPRGREETQY/TRBJ2-5, at these time points. To determine the functional compartment within which this specific clonotype resided at the 21 month time point, before antigen decay, we sorted 4 different functional populations from the HLA-B*0702-restricted FL9-specific CD8 T cell population and performed a DNA-based clonotypic analysis as described previously(35). The following 4 functional CD8 T cell populations were sorted: 3+ (IFN-γ+TNF+IL-2+), 2+ (IFN-γ+TNF+ and IFN-γ+IL2+) and 1+ (IFN-γ+). The TRBV18/CASSPRGREETQY/TRBJ2-5 clonotype was present in all 4 functional populations sorted; in contrast, the dominant TRBV18/CASSPRGRDETQY/TRBJ2-5 clonotype prior to escape was not detected(Figure 5C). We also performed a phenotypic analysis of FL9-specific CD8 T cells at the 21 month time point with or without stimulation, and compared the tetramer+ cells on the basis of IFN-γ production. No significant phenotypic differences were detected between the responding and non-responding cells that could differentiate the TRBV18/CASSPRGREETQY/TRBJ2-5 clonotype (Figure 5C). Thus, functionally superior clonotypes can persist preferentially under conditions of limited antigenic stimulation.
Functionally sensitive HIV-specific CD8 T cell clonotypes persist after antigen decay
HIV-specific CD8 T cells from subjects 5, 7 and 8 (Table 1) were stimulated with the corresponding cognate peptides to determine if increased functional sensitivity contributed to the selective persistence of HIV-specific TCR clonotypes under conditions of limited antigenic stimulation. Intracellular cytokine staining was performed to assess functionality at different peptide concentrations, with the underlying hypothesis being that clonotypes with the highest levels of functional sensitivity would be enriched in the persisting CD8 T cell population. In all cases, the EC50 values for IFN-γ production bytetramer+ CD8 T cell populations decreased over time, concomitant with the emergence of escape mutations within the corresponding cognate epitopes. Thus, the functional sensitivity of persistent antigen-specific CD8 T cells increased in the presence of low antigen levels in these 3 subjects, suggesting that this parameter confers individual clonotypes with a selection advantage in vivo in the presence of limited antigen load.
Table 1
Table 1
Antigen sensitivity in the context of antigen decay
In this study, we investigated the impact of declining antigen load on the persistence, phenotypic status andfunctionality of HIV-specific CD8 T cell populations at the clonal level. A marked degree of clonotypic turnover was observed within HIV-specific CD8 T cell populations as a consequence of antigen decay after the initiation of HAART or upon the emergence of viral epitope mutations. Furthermore, new cognate clonotypes emerged under conditions of limited antigen load. In contrast, the contemporaneous CMV-specific CD8 T cell repertoires remained stable. Antigen decay led to changes in the phenotype of HIV-specific CD8 T cells and to the acquisition of novel functions; CMV-specific CD8 T cells remained polyfunctional throughout and maintained their phenotypic profiles. HIV-specific CD8 T cell clonotypes that persisted over time exhibited functional and phenotypic changes that paralleled alterations in antigen load. Moreover, particular clonotypes that became dominant after antigen decay were selected for their higher functional capacities. Overall, these data provide clear evidence of a functional reconstitution within the HIV-specific CD8 T cell compartment upon antigen decay, which can be attributed to two non-exclusive mechanisms: (i) gain of function by persistent clonotypes; and, (ii) selection of clonotypes with high levels of functional sensitivity.
After antigen decay, we observed increases in CD127 and CD45RA expression and decreases in PD-1 expression within HIV-specific CD8 T cell populations, consistent with previous reports (22, 23, 42-45).However, these changes were not drastic; indeed, HIV-specific CD8 T cells remained predominantly CD27+. The functional improvement of HIV-specific CD8 T cell populations observed after antigen decay was primarily due to the acquisition of TNF production. Of note, the loss of TNF production has been described as an early functional marker of exhaustion (10). Furthermore, CMV-specific CD8 T cell populations in the present study exhibited similar functional and phenotypic properties throughout all time points studied. Thus, the gain of TNF production is limited to the HIV-specific CD8 T cell compartment and can be attributed to antigen decay.It should be noted that we cannot comment directly on changes in cytolytic activity because CD107 mobilization is an indicator of degranulationand may not reflect the expression of key cytolytic molecules, which show substantial heterogeneity within CD8 T cell populations (46, 47). Nonetheless, it is intriguing to postulate that the improved functionality of wild type epitope-specific CD8 T cells observed after viral escape might not only be the consequence of antigen decay but could also contribute to the generation and maintenance of HIV escape mutants. In addition, althoughthe functional improvementof HIV-specific CD8 T cells was partially sustained after the discontinuation of HAART, this was not associated with improved control of viral replication in the 4 subjects studied in this context.Given that a previous report has suggested such an association in a small number of individuals(48), further work is warranted to determine the conditions under whichthese parameters can be linked.
HIV-specific CD8 T cell repertoires tend to be oligoclonal and skewed during chronic HIV-1 infection, likely as a consequence of several factors including avidity-based selection(41), the loss of high avidity clonotypes (49) and a relative lack of precursor T cell diversity due to decreased thymic output(50). In the present study, we observed that reduced antigenic stimulation resulted in dynamic HIV-specific CD8 T cell repertoire changes, including the emergence of new clonotypes, modifications of clonal dominance and reductions in the overall numbers of constituent clonotypes. Of note, we observed a degree of cross-reactivity between wild type and variant epitopes in subject 7. In this scenario, TCR repertoire alterations were minimal, consistent with a degree of ongoing antigenic drive mediated by the variant epitope. Thus, cross-reactivity can modify the impact of epitope mutation on the wild type antigen-specific CD8 T cell repertoire.
The emergence of new clonotypes after antigen decay was observed after the institution of HAART and following the emergence of viral epitope mutations. However, the origins of these clonotypes remain to be elucidated. One possibility is that these clonotypes exit secondary lymphoid organs as antigen loaddecreases. De novo priming of new clonotypes is also known to occur during persistent viral infections(51), and may even be enhanced by improved CD4 T cell help during HAART and residual low level antigen persistence (52, 53). With the application of deep sequencing approaches to the evaluation of mutational immune escape, it is becoming clear that wild type antigen frequently persists to some extent within complex mixtures of viral variants and it is probable that such viral quasispecies establish an equilibrium with the residual cognate CD8 T cell population by priming new functional clonotypes(54). Finally, the apparent emergence of new clonotypes may simply represent a relative increase in the frequency of previously primed memory CD8 T cell clonotypes that were harbored below the level of detection at earlier time points(55). The application of more sensitive methodologies for TCR repertoire evaluation could help to resolve these issues(56).
Our experiments also allowed us to determine whether the overall restoration of functional capacity within HIV-specific CD8 T cell populations was the consequence of a functional improvement at the single cell level or the preferential survival of poly-functional CD8 T cells. Overall, the data indicate that both mechanisms contribute to the observed functional restoration within HIV-specific CD8 T cell populations under conditions of limited antigenic stimulation. Thus, antigen decay, due either to effective HAART or the emergence of epitope mutations, led to a significant change in the TCR repertoiredue to the selection of clonotypes with high levels of functional sensitivity. In addition, individual clonotypes were shown to undergo functional improvement under the same conditions. Consistent with these observations, Reeset al. showed that antigen load in peptide-immunized mice shaped the CD4 T cell repertoire, and that high antigen load led to the emergence of clonotypes with low levels of functional sensitivity (57). Moreover, it was reported previously that CD8 T cells with high levels of antigen sensitivity exhibited superior effector functions resulting in more efficient antiviral activity compared to CD8 T cells with poor antigen sensitivity(41, 58-63). In addition, Almeida et al. showed thatepitope-specific CD8 T cell clones endowed with high levels of antigen sensitivity displayed superior functionality, proliferated more efficiently and mediated more potent HIV-1 suppressive activity(6, 64). Our data suggest that clonotypes with higher levels of antigen sensitivity could also have a superior capacity to persist in vivo, thereby highlighting the need to define optimal concentrations of antigen for the generation of long-lived memory CD8 T cell clonotypes with maximal antiviral efficacy. Collectively, these findings have implications for vaccination and lend support to immunotherapeutic strategies that aim to induce polyclonal responses under conditions of HAART (65).
Supplementary Material
Acknowledgements
We would like to thank Dr. Nicolas Chomont and Dr. Rabih Halwani for their objective comments, Dr. Vanessa Venturi for her advice,members of the Cleveland Immunopathogenesis Consortium for helpful discussionsand the Reseau FRSQ SIDA-MI for providing the samples used in this study.
This work was supported by funds from the CIHR, the FRSQ SIDA-MI, the NIH (IDPIDA028871-01) and the Office of Tourism, Trade and Economic Development of Florida.DAP is a Medical Research Council (UK) Senior Clinical Fellow.
1. Borrow P, Lewicki H, Hahn BH, Shaw GM, Oldstone MB. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol. 1994;68:6103–6110. [PMC free article] [PubMed]
2. Koup RA, Safrit JT, Cao Y, Andrews CA, McLeod G, Borkowsky W, Farthing C, Ho DD. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol. 1994;68:4650–4655. [PMC free article] [PubMed]
3. Jin X, Bauer DE, Tuttleton SE, Lewin S, Gettie A, Blanchard J, Irwin CE, Safrit JT, Mittler J, Weinberger L, Kostrikis LG, Zhang L, Perelson AS, Ho DD. Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques. J Exp Med. 1999;189:991–998. [PMC free article] [PubMed]
4. Schmitz JE, Kuroda MJ, Santra S, Sasseville VG, Simon MA, Lifton MA, Racz P, Tenner-Racz K, Dalesandro M, Scallon BJ, Ghrayeb J, Forman MA, Montefiori DC, Rieber EP, Letvin NL, Reimann KA. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science. 1999;283:857–860. [PubMed]
5. Betts MR, Nason MC, West SM, De Rosa SC, Migueles SA, Abraham J, Lederman MM, Benito JM, Goepfert PA, Connors M, Roederer M, Koup RA. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood. 2006;107:4781–4789. [PubMed]
6. Almeida JR, Price DA, Papagno L, Arkoub ZA, Sauce D, Bornstein E, Asher TE, Samri A, Schnuriger A, Theodorou I, Costagliola D, Rouzioux C, Agut H, Marcelin AG, Douek D, Autran B, Appay V. Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover. J Exp Med. 2007;204:2473–2485. [PMC free article] [PubMed]
7. Appay V, Nixon DF, Donahoe SM, Gillespie GM, Dong T, King A, Ogg GS, Spiegel HM, Conlon C, Spina CA, Havlir DV, Richman DD, Waters A, Easterbrook P, McMichael AJ, Rowland-Jones SL. HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function. J Exp Med. 2000;192:63–75. [PMC free article] [PubMed]
8. Shankar P, Russo M, Harnisch B, Patterson M, Skolnik P, Lieberman J. Impaired function of circulating HIV-specific CD8(+) T cells in chronic human immunodeficiency virus infection. Blood. 2000;96:3094–3101. [PubMed]
9. Migueles SA, Laborico AC, Shupert WL, Sabbaghian MS, Rabin R, Hallahan CW, Van Baarle D, Kostense S, Miedema F, McLaughlin M, Ehler L, Metcalf J, Liu S, Connors M. HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat Immunol. 2002;3:1061–1068. [PubMed]
10. Wherry EJ, Blattman JN, Murali-Krishna K, van der Most R, Ahmed R. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J Virol. 2003;77:4911–4927. [PMC free article] [PubMed]
11. Wherry EJ, Ahmed R. Memory CD8 T-cell differentiation during viral infection. J Virol. 2004;78:5535–5545. [PMC free article] [PubMed]
12. Day CL, Kaufmann DE, Kiepiela P, Brown JA, Moodley ES, Reddy S, Mackey EW, Miller JD, Leslie AJ, DePierres C, Mncube Z, Duraiswamy J, Zhu B, Eichbaum Q, Altfeld M, Wherry EJ, Coovadia HM, Goulder PJ, Klenerman P, Ahmed R, Freeman GJ, Walker BD. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature. 2006;443:350–354. [PubMed]
13. Trautmann L, Janbazian L, Chomont N, Said EA, Gimmig S, Bessette B, Boulassel MR, Delwart E, Sepulveda H, Balderas RS, Routy JP, Haddad EK, Sekaly RP. Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. Nat Med. 2006;12:1198–1202. [PubMed]
14. Casazza JP, Betts MR, Picker LJ, Koup RA. Decay kinetics of human immunodeficiency virus-specific CD8+ T cells in peripheral blood after initiation of highly active antiretroviral therapy. J Virol. 2001;75:6508–6516. [PMC free article] [PubMed]
15. Ogg GS, Jin X, Bonhoeffer S, Moss P, Nowak MA, Monard S, Segal JP, Cao Y, Rowland-Jones SL, Hurley A, Markowitz M, Ho DD, McMichael AJ, Nixon DF. Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy. J Virol. 1999;73:797–800. [PMC free article] [PubMed]
16. Altfeld M, Rosenberg ES, Shankarappa R, Mukherjee JS, Hecht FM, Eldridge RL, Addo MM, Poon SH, Phillips MN, Robbins GK, Sax PE, Boswell S, Kahn JO, Brander C, Goulder PJ, Levy JA, Mullins JI, Walker BD. Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection. J Exp Med. 2001;193:169–180. [PMC free article] [PubMed]
17. Allen TM, Yu XG, Kalife ET, Reyor LL, Lichterfeld M, John M, Cheng M, Allgaier RL, Mui S, Frahm N, Alter G, Brown NV, Johnston MN, Rosenberg ES, Mallal SA, Brander C, Walker BD, Altfeld M. De novo generation of escape variant-specific CD8+ T-cell responses following cytotoxic T-lymphocyte escape in chronic human immunodeficiency virus type 1 infection. J Virol. 2005;79:12952–12960. [PMC free article] [PubMed]
18. Barouch DH, Powers J, Truitt DM, Kishko MG, Arthur JC, Peyerl FW, Kuroda MJ, Gorgone DA, Lifton MA, Lord CI, Hirsch VM, Montefiori DC, Carville A, Mansfield KG, Kunstman KJ, Wolinsky SM, Letvin NL. Dynamic immune responses maintain cytotoxic T lymphocyte epitope mutations in transmitted simian immunodeficiency virus variants. Nat Immunol. 2005;6:247–252. [PubMed]
19. Friedrich TC, Dodds EJ, Yant LJ, Vojnov L, Rudersdorf R, Cullen C, Evans DT, Desrosiers RC, Mothe BR, Sidney J, Sette A, Kunstman K, Wolinsky S, Piatak M, Lifson J, Hughes AL, Wilson N, O’Connor DH, Watkins DI. Reversion of CTL escape-variant immunodeficiency viruses in vivo. Nat Med. 2004;10:275–281. [PubMed]
20. Goulder PJ, Brander C, Tang Y, Tremblay C, Colbert RA, Addo MM, Rosenberg ES, Nguyen T, Allen R, Trocha A, Altfeld M, He S, Bunce M, Funkhouser R, Pelton SI, Burchett SK, McIntosh K, Korber BT, Walker BD. Evolution and transmission of stable CTL escape mutations in HIV infection. Nature. 2001;412:334–338. [PubMed]
21. Leslie AJ, Pfafferott KJ, Chetty P, Draenert R, Addo MM, Feeney M, Tang Y, Holmes EC, Allen T, Prado JG, Altfeld M, Brander C, Dixon C, Ramduth D, Jeena P, Thomas SA, St John A, Roach TA, Kupfer B, Luzzi G, Edwards A, Taylor G, Lyall H, Tudor-Williams G, Novelli V, Martinez-Picado J, Kiepiela P, Walker BD, Goulder PJ. HIV evolution: CTL escape mutation and reversion after transmission. Nat Med. 2004;10:282–289. [PubMed]
22. Rehr M, Cahenzli J, Haas A, Price DA, Gostick E, Huber M, Karrer U, Oxenius A. Emergence of polyfunctional CD8+ T cells after prolonged suppression of human immunodeficiency virus replication by antiretroviral therapy. J Virol. 2008;82:3391–3404. [PMC free article] [PubMed]
23. Streeck H, Brumme ZL, Anastario M, Cohen KW, Jolin JS, Meier A, Brumme CJ, Rosenberg ES, Alter G, Allen TM, Walker BD, Altfeld M. Antigen load and viral sequence diversification determine the functional profile of HIV-1-specific CD8+ T cells. PLoS Med. 2008;5:e100. [PMC free article] [PubMed]
24. Vollbrecht T, Brackmann H, Henrich N, Roeling J, Seybold U, Bogner JR, Goebel FD, Draenert R. Impact of changes in antigen level on CD38/PD-1 co-expression on HIV-specific CD8 T cells in chronic, untreated HIV-1 infection. J Med Virol. 2010;82:358–370. [PubMed]
25. Nikolich-Zugich J, Slifka MK, Messaoudi I. The many important facets of T-cell repertoire diversity. Nat Rev Immunol. 2004;4:123–132. [PubMed]
26. Turner SJ, Doherty PC, McCluskey J, Rossjohn J. Structural determinants of T-cell receptor bias in immunity. Nat Rev Immunol. 2006;6:883–894. [PubMed]
27. Davenport MP, Price DA, McMichael AJ. The T cell repertoire in infection and vaccination: implications for control of persistent viruses. Curr Opin Immunol. 2007;19:294–300. [PubMed]
28. Venturi V, Price DA, Douek DC, Davenport MP. The molecular basis for public T-cell responses? Nat Rev Immunol. 2008;8:231–238. [PubMed]
29. Turner SJ, La Gruta NL, Kedzierska K, Thomas PG, Doherty PC. Functional implications of T cell receptor diversity. Curr Opin Immunol. 2009;21:286–290. [PMC free article] [PubMed]
30. Conrad JA, Ramalingam RK, Smith RM, Barnett L, Lorey SL, Wei J, Simons BC, Sadagopal S, Meyer-Olson D, Kalams SA. Dominant Clonotypes within HIV-Specific T Cell Responses Are Programmed Death-1high and CD127low and Display Reduced Variant Cross-Reactivity. J Immunol. 2011;186:6871–6885. [PMC free article] [PubMed]
31. Bernardin F, Herring BL, Peddada L, Delwart EL. Primary infection of a male plasma donor with divergent HIV variants from the same source followed by rapid fluctuations in their relative frequency and viral recombination. AIDS Res Hum Retroviruses. 2003;19:1009–1015. [PubMed]
32. Altman JD, Moss PA, Goulder PJ, Barouch DH, McHeyzer-Williams MG, Bell JI, McMichael AJ, Davis MM. Phenotypic analysis of antigen-specific T lymphocytes. Science. 1996;274:94–96. [PubMed]
33. Roederer M, Nozzi JL, Nason MC. SPICE: exploration and analysis of post-cytometric complex multivariate datasets. Cytometry A. 2011;79:167–174. [PMC free article] [PubMed]
34. Douek DC, Betts MR, Brenchley JM, Hill BJ, Ambrozak DR, Ngai KL, Karandikar NJ, Casazza JP, Koup RA. A novel approach to the analysis of specificity, clonality, and frequency of HIV-specific T cell responses reveals a potential mechanism for control of viral escape. J Immunol. 2002;168:3099–3104. [PubMed]
35. Scheinberg P, Melenhorst JJ, Hill BJ, Keyvanfar K, Barrett AJ, Price DA, Douek DC. The clonal composition of human CD4+CD25+Foxp3+ cells determined by a comprehensive DNA-based multiplex PCR for TCRB gene rearrangements. J Immunol Methods. 2007;321:107–120. [PubMed]
36. Venturi V, Kedzierska K, Tanaka MM, Turner SJ, Doherty PC, Davenport MP. Method for assessing the similarity between subsets of the T cell receptor repertoire. J Immunol Methods. 2008;329:67–80. [PubMed]
37. Sacre K, Carcelain G, Cassoux N, Fillet AM, Costagliola D, Vittecoq D, Salmon D, Amoura Z, Katlama C, Autran B. Repertoire, diversity, and differentiation of specific CD8 T cells are associated with immune protection against human cytomegalovirus disease. J Exp Med. 2005;201:1999–2010. [PMC free article] [PubMed]
38. Champagne P, Ogg GS, King AS, Knabenhans C, Ellefsen K, Nobile M, Appay V, Rizzardi GP, Fleury S, Lipp M, Forster R, Rowland-Jones S, Sekaly RP, McMichael AJ, Pantaleo G. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature. 2001;410:106–111. [PubMed]
39. Gattinoni L, Lugli E, Ji Y, Pos Z, Paulos CM, Quigley MF, Almeida JR, Gostick E, Yu Z, Carpenito C, Wang E, Douek DC, Price DA, June CH, Marincola FM, Roederer M, Restifo NP. A human memory T cell subset with stem cell-like properties. Nature medicine. 2011;17:1290–1297. [PMC free article] [PubMed]
40. van Bockel DJ, Price DA, Munier ML, Venturi V, Asher TE, Ladell K, Greenaway HY, Zaunders J, Douek DC, Cooper DA, Davenport MP, Kelleher AD. Persistent survival of prevalent clonotypes within an immunodominant HIV gag-specific CD8+ T cell response. J Immunol. 2011;186:359–371. [PubMed]
41. Price DA, Brenchley JM, Ruff LE, Betts MR, Hill BJ, Roederer M, Koup RA, Migueles SA, Gostick E, Wooldridge L, Sewell AK, Connors M, Douek DC. Avidity for antigen shapes clonal dominance in CD8+ T cell populations specific for persistent DNA viruses. J Exp Med. 2005;202:1349–1361. [PMC free article] [PubMed]
42. Petrovas C, Price DA, Mattapallil J, Ambrozak DR, Geldmacher C, Cecchinato V, Vaccari M, Tryniszewska E, Gostick E, Roederer M, Douek DC, Morgan SH, Davis SJ, Franchini G, Koup RA. SIV-specific CD8+ T cells express high levels of PD1 and cytokines but have impaired proliferative capacity in acute and chronic SIVmac251 infection. Blood. 2007;110:928–936. [PubMed]
43. Sauce D, Almeida JR, Larsen M, Haro L, Autran B, Freeman GJ, Appay V. PD-1 expression on human CD8 T cells depends on both state of differentiation and activation status. AIDS. 2007;21:2005–2013. [PubMed]
44. Rutebemberwa A, Ray SC, Astemborski J, Levine J, Liu L, Dowd KA, Clute S, Wang C, Korman A, Sette A, Sidney J, Pardoll DM, Cox AL. High-programmed death-1 levels on hepatitis C virus-specific T cells during acute infection are associated with viral persistence and require preservation of cognate antigen during chronic infection. J Immunol. 2008;181:8215–8225. [PMC free article] [PubMed]
45. Blattman JN, Wherry EJ, Ha SJ, van der Most RG, Ahmed R. Impact of epitope escape on PD-1 expression and CD8 T-cell exhaustion during chronic infection. J Virol. 2009;83:4386–4394. [PMC free article] [PubMed]
46. Jenkins MR, Kedzierska K, Doherty PC, Turner SJ. Heterogeneity of effector phenotype for acute phase and memory influenza A virus-specific CTL. Journal of immunology. 2007;179:64–70. [PubMed]
47. Peixoto A, Evaristo C, Munitic I, Monteiro M, Charbit A, Rocha B, Veiga-Fernandes H. CD8 single-cell gene coexpression reveals three different effector types present at distinct phases of the immune response. The Journal of experimental medicine. 2007;204:1193–1205. [PMC free article] [PubMed]
48. Daucher M, Price DA, Brenchley JM, Lamoreaux L, Metcalf JA, Rehm C, Nies-Kraske E, Urban E, Yoder C, Rock D, Gumkowski J, Betts MR, Dybul MR, Douek DC. Virological outcome after structured interruption of antiretroviral therapy for human immunodeficiency virus infection is associated with the functional profile of virus-specific CD8+ T cells. Journal of virology. 2008;82:4102–4114. [PMC free article] [PubMed]
49. Lichterfeld M, Yu XG, Mui SK, Williams KL, Trocha A, Brockman MA, Allgaier RL, Waring MT, Koibuchi T, Johnston MN, Cohen D, Allen TM, Rosenberg ES, Walker BD, Altfeld M. Selective depletion of high-avidity human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T cells after early HIV-1 infection. J Virol. 2007;81:4199–4214. [PMC free article] [PubMed]
50. Douek DC, McFarland RD, Keiser PH, Gage EA, Massey JM, Haynes BF, Polis MA, Haase AT, Feinberg MB, Sullivan JL, Jamieson BD, Zack JA, Picker LJ, Koup RA. Changes in thymic function with age and during the treatment of HIV infection. Nature. 1998;396:690–695. [PubMed]
51. Vezys V, Masopust D, Kemball CC, Barber DL, O’Mara LA, Larsen CP, Pearson TC, Ahmed R, Lukacher AE. Continuous recruitment of naive T cells contributes to heterogeneity of antiviral CD8 T cells during persistent infection. J Exp Med. 2006;203:2263–2269. [PMC free article] [PubMed]
52. Chun TW, Nickle DC, Justement JS, Large D, Semerjian A, Curlin ME, O’Shea MA, Hallahan CW, Daucher M, Ward DJ, Moir S, Mullins JI, Kovacs C, Fauci AS. HIV-infected individuals receiving effective antiviral therapy for extended periods of time continually replenish their viral reservoir. J Clin Invest. 2005;115:3250–3255. [PMC free article] [PubMed]
53. Palmer S, Maldarelli F, Wiegand A, Bernstein B, Hanna GJ, Brun SC, Kempf DJ, Mellors JW, Coffin JM, King MS. Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy. Proc Natl Acad Sci U S A. 2008;105:3879–3884. [PubMed]
54. Bimber BN, Burwitz BJ, O’Connor S, Detmer A, Gostick E, Lank SM, Price DA, Hughes A, O’Connor D. Ultradeep pyrosequencing detects complex patterns of CD8+ T-lymphocyte escape in simian immunodeficiency virus-infected macaques. J Virol. 2009;83:8247–8253. [PMC free article] [PubMed]
55. Price DA, Bitmansour AD, Edgar JB, Walker JM, Axthelm MK, Douek DC, Picker LJ. Induction and evolution of cytomegalovirus-specific CD4+ T cell clonotypes in rhesus macaques. J Immunol. 2008;180:269–280. [PubMed]
56. Venturi V, Greenaway HY QM, Ng PC, Ende ZS, McIntosh T, Asher TE, Almeida JR, Levy S, Price DA, Davenport MP, Douek DC. A mechanism for T cell receptor sharing between T cell subsets and individuals revealed by pyrosequencing. J Immunol. 2011;186(7):4285–4294. [PubMed]
57. Rees W, Bender J, Teague TK, Kedl RM, Crawford F, Marrack P, Kappler J. An inverse relationship between T cell receptor affinity and antigen dose during CD4(+) T cell responses in vivo and in vitro. Proc Natl Acad Sci U S A. 1999;96:9781–9786. [PubMed]
58. Alexander-Miller MA, Leggatt GR, Berzofsky JA. Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy. Proc Natl Acad Sci U S A. 1996;93:4102–4107. [PubMed]
59. Derby M, Alexander-Miller M, Tse R, Berzofsky J. High-avidity CTL exploit two complementary mechanisms to provide better protection against viral infection than low-avidity CTL. J Immunol. 2001;166:1690–1697. [PubMed]
60. Sedlik C, Dadaglio G, Saron MF, Deriaud E, Rojas M, Casal SI, Leclerc C. In vivo induction of a high-avidity, high-frequency cytotoxic T-lymphocyte response is associated with antiviral protective immunity. J Virol. 2000;74:5769–5775. [PMC free article] [PubMed]
61. La Gruta NL, Turner SJ, Doherty PC. Hierarchies in cytokine expression profiles for acute and resolving influenza virus-specific CD8+ T cell responses: correlation of cytokine profile and TCR avidity. J Immunol. 2004;172:5553–5560. [PubMed]
62. Bihl F, Frahm N, Di Giammarino L, Sidney J, John M, Yusim K, Woodberry T, Sango K, Hewitt HS, Henry L, Linde CH, Chisholm JV, 3rd, Zaman TM, Pae E, Mallal S, Walker BD, Sette A, Korber BT, Heckerman D, Brander C. Impact of HLA-B alleles, epitope binding affinity, functional avidity, and viral coinfection on the immunodominance of virus-specific CTL responses. J Immunol. 2006;176:4094–4101. [PubMed]
63. Day EK, Carmichael AJ, ten Berge IJ, Waller EC, Sissons JG, Wills MR. Rapid CD8+ T cell repertoire focusing and selection of high-affinity clones into memory following primary infection with a persistent human virus: human cytomegalovirus. J Immunol. 2007;179:3203–3213. [PubMed]
64. Almeida JR, Sauce D, Price DA, Papagno L, Shin SY, Moris A, Larsen M, Pancino G, Douek DC, Autran B, Saez-Cirion A, Appay V. Antigen sensitivity is a major determinant of CD8+ T-cell polyfunctionality and HIV-suppressive activity. Blood. 2009;113:6351–6360. [PubMed]
65. Perrin H, Canderan G, Sekaly RP, Trautmann L. New approaches to design HIV-1 T-cell vaccines. Curr Opin HIV AIDS. 2010;5:368–376. [PMC free article] [PubMed]